Pharmacologic interventions | |
Drug | Dosing |
Oxytocin (first-line) | 10 to 40 units in 500 to 1000 mL normal saline infused at a rate sufficient to control atony or 5 to 10 units IM. |
Tranexamic acid (adjunctive agent) | 1 g (10 mL of a 100 mg/mL solution) is infused over 10 to 20 minutes; if bleeding persists after 30 minutes, a second 1 g dose is administered. |
Ergots (second-line) | Methylergonovine 0.2 mg IM or ergonovine 0.2 mg IM every 2 to 4 hours. |
Carboprost (second-line) | 0.25 mg IM every 15 to 90 minutes up to 8 doses. |
Misoprostol | 400 to 800 mcg sublingually as a single dose. Most useful in settings where injectable uterotonics are unavailable or contraindicated (eg, hypertension, asthma) |
Recombinant human factor VIIa (adjunctive agent) | 50 to 100 mcg/kg. It is preferable to start with a low dose (40 or 60 mcg/kg). The dose may be repeated once in 15 to 30 minutes if there is no response. Additional doses are unlikely to be effective. |
Surgical interventions | |
| |
Interventional endovascular procedures | |
| |
Blood bank | |
| |
Nonsurgical interventions | |
| |
Consultations | |
|
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟